Published in Stroke on September 01, 2000
Varicella zoster virus vasculopathy: analysis of virus-infected arteries. Neurology (2011) 2.71
Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system. J Acquir Immune Defic Syndr (2012) 1.85
Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms. AIDS (2004) 1.75
HIV infection and stroke: current perspectives and future directions. Lancet Neurol (2012) 1.66
Stroke in patients with human immunodeficiency virus infection. J Neurol Neurosurg Psychiatry (2007) 1.55
Brain arterial remodeling contribution to nonembolic brain infarcts in patients with HIV. Neurology (2015) 1.45
Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. Brain Res (2011) 1.29
Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the Southeastern United States. AIDS Res Hum Retroviruses (2013) 1.15
Increasing incidence of ischemic stroke in patients with HIV infection. Neurology (2011) 1.14
Virus vasculopathy and stroke: an under-recognized cause and treatment target. Infect Disord Drug Targets (2010) 1.11
Role of metabolic syndrome components in human immunodeficiency virus-associated stroke. J Neurovirol (2009) 1.01
The contribution of HIV infection to intracranial arterial remodeling: a pilot study. Neuropathology (2012) 0.97
Pattern of heart failure in a Nigerian teaching hospital. Vasc Health Risk Manag (2009) 0.93
HIV protease inhibitor exposure predicts cerebral small vessel disease. AIDS (2014) 0.92
Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals. Curr Opin Investig Drugs (2010) 0.91
Stroke in young adults: a prospective study from northwestern Nigeria. ISRN Neurol (2012) 0.91
Relationship between Younger Age, Autoimmunity, Cardiometabolic Risk, Oxidative Stress, HAART, and Ischemic Stroke in Africans with HIV/AIDS. ISRN Cardiol (2011) 0.89
Arterial ischemic stroke in HIV: Defining and classifying etiology for research studies. Neurol Neuroimmunol Neuroinflamm (2016) 0.81
Brain large artery inflammation associated with HIV and large artery remodeling. AIDS (2016) 0.80
Unilateral herpes zoster ophthalmicus with bilateral cerebral infarcts in human immunodeficiency virus seropositive patient. J Neurosci Rural Pract (2014) 0.75
Stroke in a Patient with Tuberculous Meningitis and HIV Infection. Mediterr J Hematol Infect Dis (2013) 0.75
[Incidence of strokes in HIV-positive patients treated with long term antiretroviral treatment]. Pan Afr Med J (2016) 0.75
Aneurysmal vasculopathy in human-acquired immunodeficiency virus-infected adults: Imaging case series and review of the literature. Interv Neuroradiol (2015) 0.75
Increased Cortical Cerebral Blood Flow in Asymptomatic Human Immunodeficiency Virus-Infected Subjects. J Stroke Cerebrovasc Dis (2016) 0.75
Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet (2004) 7.33
Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol (1993) 6.41
A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet (2005) 6.14
Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet (2004) 5.93
Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet (2003) 5.90
Interobserver agreement for the assessment of handicap in stroke patients. Stroke (1989) 4.39
General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial. Lancet (2008) 4.18
Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke (1997) 4.07
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet (1996) 4.05
Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet (1999) 4.02
A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology (1994) 4.01
Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet (1999) 3.97
Syndromes of transient amnesia: towards a classification. A study of 153 cases. J Neurol Neurosurg Psychiatry (1990) 3.96
Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol (1998) 3.77
Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke. Lancet (1997) 3.76
Managing patients with lung cancer. New guidelines should improve standards of care. BMJ (1999) 3.65
Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc Natl Acad Sci U S A (1992) 3.58
Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol (1992) 3.37
HCV confirmatory testing of blood donors. Lancet (1991) 3.29
Testing of blood donations for hepatitis C virus. Lancet (1994) 3.27
Very early risk of stroke after a first transient ischemic attack. Stroke (2003) 3.26
Infection with hepatitis G virus among recipients of plasma products. Lancet (1996) 3.25
Symptomatic carotid ischaemic events: safest and most cost effective way of selecting patients for angiography, before carotid endarterectomy. BMJ (1990) 3.20
A role for medical angiologists? BMJ (1993) 3.18
Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol (1995) 3.10
Evidence of a chronic systemic cause of instability of atherosclerotic plaques. Lancet (2000) 3.07
Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists' Collaborative Group. Lancet (1999) 3.05
Epidemiological profile and clinical associations of human bocavirus and other human parvoviruses. J Infect Dis (2006) 2.97
Rapid resolution of signs of primary intracerebral haemorrhage in computed tomograms of the brain. Br Med J (Clin Res Ed) (1987) 2.96
Incidence of transient ischemic attacks in Oxfordshire, England. Stroke (1989) 2.94
Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.91
Clinical diagnosis of intracranial haemorrhage using Guy's Hospital score. Br Med J (Clin Res Ed) (1985) 2.85
Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity. J Virol (2001) 2.79
Effect of correcting outcome data for case mix: an example from stroke medicine. BMJ (1996) 2.79
Ethical review of a multicentre study in Scotland: a weighty problem. J R Coll Physicians Lond (2000) 2.77
How well does the Oxfordshire community stroke project classification predict the site and size of the infarct on brain imaging? J Neurol Neurosurg Psychiatry (2000) 2.72
Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: rate of sequence change and low frequency of inactivating mutations. J Virol (1990) 2.68
Cerebral angiographic risk in mild cerebrovascular disease. Stroke (1990) 2.65
Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system. J Virol (2001) 2.62
Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology (1994) 2.60
Physiotherapy intervention late after stroke and mobility. BMJ (1992) 2.57
Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy. Gastroenterology (1996) 2.48
Effects of phospholipid surface charge on ion conduction in the K+ channel of sarcoplasmic reticulum. Biophys J (1984) 2.46
Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut (1998) 2.45
Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke (1993) 2.44
CSF opening pressure: reference interval and the effect of body mass index. Neurology (2006) 2.39
The aetiology of transient global amnesia. A case-control study of 114 cases with prospective follow-up. Brain (1990) 2.26
The origin of hepatitis C virus genotypes. J Gen Virol (1997) 2.26
Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion (1993) 2.24
Varicella-zoster virus gene expression in latently infected and explanted human ganglia. J Virol (2000) 2.23
Thrombolysis in acute ischemic stroke: does it work? Stroke (1992) 2.23
A highly divergent picornavirus in a marine mammal. J Virol (2007) 2.23
Prevalence of stroke survivors in rural South Africa: results from the Southern Africa Stroke Prevention Initiative (SASPI) Agincourt field site. Stroke (2004) 2.22
Complications after acute stroke. Stroke (1996) 2.21
Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group. Lancet (1996) 2.20
Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. J Clin Oncol (1999) 2.19
Local versus general anaesthesia in carotid endarterectomy: a systematic review of the evidence. Eur J Vasc Endovasc Surg (1997) 2.13
Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol (1997) 2.13
Carotid endarterectomy and the measurement of stenosis. Stroke (1993) 2.10
Virus 'quasispecies': making a mountain out of a molehill? J Gen Virol (1997) 2.07
Detection of bilateral isodense subdural haematomas. BMJ (1994) 2.03
HTLV-III antibody in Edinburgh drug addicts. Lancet (1985) 2.03
Does the angiographic appearance of a carotid stenosis predict the risk of stroke independently of the degree of stenosis? Clin Radiol (1995) 2.02
Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.00
Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol (2005) 1.98
Clinical and angiographic predictors of stroke and death from carotid endarterectomy: systematic review. BMJ (1997) 1.97
No evidence for an association between infections with WU and KI polyomaviruses and respiratory disease. J Clin Virol (2007) 1.96
The molecular epidemiology of human immunodeficiency virus type 1 in Edinburgh. J Infect Dis (1995) 1.94
Differentiating between audit and research. Undue protection of patient confidentiality jeopardises both research and audit. BMJ (2000) 1.93
Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates. AIDS (1991) 1.93
Characteristics of nucleotide substitution in the hepatitis C virus genome: constraints on sequence change in coding regions at both ends of the genome. J Mol Evol (1997) 1.88
The 12 year prognosis of unilateral functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry (2003) 1.78
Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann Neurol (2000) 1.75
The prognosis of hospital-referred transient ischaemic attacks. J Neurol Neurosurg Psychiatry (1991) 1.73
Serological responses to infection with three different types of hepatitis C virus. Lancet (1991) 1.73
Comparing stroke incidence worldwide: what makes studies comparable? Stroke (1996) 1.72
Amount of research interest in rare and common neurological conditions: bibliometric study. BMJ (2001) 1.68
Epidemiology and clinical associations of human parechovirus respiratory infections. J Clin Microbiol (2008) 1.68
Confirmation of hepatitis C virus antibody in blood donors. J Med Virol (1993) 1.68
Genotype dependence of hepatitis C virus load measurement in commercially available quantitative assays. J Clin Microbiol (1999) 1.68
A comparison of risk factors and prognosis for transient ischemic attacks and minor ischemic strokes. The Oxfordshire Community Stroke Project. Stroke (1989) 1.67
Hepatic microsomal glucose-6-phosphatase system and sudden infant death syndrome. Lancet (1989) 1.66
HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain (1998) 1.65
Heterosexual transmission of hepatitis C virus. Lancet (1993) 1.65
Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia. J Neurol Neurosurg Psychiatry (1999) 1.63
Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia. AIDS (2000) 1.63
Familial breast cancer: an investigation into the outcome of treatment for early stage disease. Fam Cancer (2001) 1.62
Detailed mapping of RNA secondary structures in core and NS5B-encoding region sequences of hepatitis C virus by RNase cleavage and novel bioinformatic prediction methods. J Gen Virol (2004) 1.62
HIV-1 tropism and co-receptor use. Nature (1997) 1.60
The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register. J Neurol (1993) 1.60
Hospital services for patients with acute stroke in the United Kingdom: the Stroke Association Survey of consultant opinion. Age Ageing (1995) 1.59
Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group. Ann Intern Med (1996) 1.56
First coitus before menarche and risk of sexually transmitted disease. Lancet (1990) 1.55
Hepatitis C virus (HCV) genotypes and chronic liver disease in Pakistan. J Gastroenterol Hepatol (1997) 1.55
Molecular investigation of human immunodeficiency virus (HIV) infection in a patient of an HIV-infected surgeon. J Infect Dis (1993) 1.54
Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet (1995) 1.54